專家采訪：Independent Pharmaceutical Consultant Deepak Hegde

熱門推薦：制藥在線 , Deepak Hegde , 新藥出海 , 新興市場 , 非洲市場 ,

來源：CPHI制藥在線

2024-07-16

CPHI & PMEC China2024展會(huì)現(xiàn)場，制藥在線很榮幸采訪到Independent Pharmaceutical Consultant Deepak Hegde，探討如下話題。

制藥在線專家訪談

2024年6月19日-21日，由Informa Markets、中國醫(yī)藥保健品進(jìn)出口商會(huì)主辦、上海博華國際展覽有限公司協(xié)辦的“第二十二屆世界制藥原料中國展”（CPHI China 2024）攜手“第十七屆世界制藥機(jī)械、包裝設(shè)備與材料中國展”（PMEC China 2024）在上海新國際博覽中心隆重舉行。制藥在線作為CPHI & PMEC China 展會(huì)官方線上服務(wù)平臺(tái)深度參與了這場制藥工業(yè)盛會(huì)。我們以“新藥出海”為主題，獨(dú)家采訪了二十位制藥行業(yè)資深專家。通過專家們多元化的視角與深刻的見解，我們共同展望出海藍(lán)圖，探尋制藥行業(yè)創(chuàng)新發(fā)展方向，為中國制藥的國際化征程推波助瀾。

本次展會(huì)，制藥在線很榮幸采訪到Independent Pharmaceutical Consultant Deepak Hegde，探討如下話題：

1、Hello，Dr. Hegde, welcome back to CPHI 2024 again! As more and more Chinese pharmaceutical companies are taking globalization as one of their most important stratetigies, what are the factors that need to be taken into consideration when an innovative drug company plan to go global for the products?

2、How important is international cooperation in the process of globalization for the drug companies? Do you have any tips for the pharmaceutical companies when selecting suppliers in the whole life-cycle?

3、As the companies are turning their eyes on emerging markets, and also as you have experiences of drug registration in South Africa, could you introduce what are the special aspects for drug registration in African market?

專家簡介：

Independent Pharmaceutical Consultant Deepak Hegde

Deepak Hegde

Independent Pharmaceutical Consultant

Deepak Hegde, Ph.D., M.F.M, is an industrial pharmacist by training. He has a been involved in development and commercialization of both innovative and generic drugs from a very early phase of development to technical transfers for commercial manufacturing sites, for the past 28 years, having extensive experience in generic formulation development of solid and liquid oral and injectible formulations from a very early phase of development all the way to technical transfers to commercial manufacturing sites. During his career, he has worked at Rhone Poulenc, Novartis (Sandoz), USV Ltd., WuXi AppTec, GSK & EOC Pharma and Pharmacin. Dr. Deepak Hegde completed his Doctorate in Biopharmaceutics and Pharmacokinetics from University of Mumbai in 1996. He also completed his Masters in Financial Management (M.F.M) from University of Mumbai in 2000. He is currently working as an Independent Pharmaceutical Consultant at Hegde Asociates.

版權(quán)所有，未經(jīng)允許，不得轉(zhuǎn)載。